Ophthalmology

Biocon Biologics is deeply committed to preserving vision and improving lives by transforming access to high-quality ophthalmology treatments. Guided by a patient-first purpose, we strive to make advanced retinal therapies accessible, sustainable, and affordable across global healthcare systems. Leveraging our strong biologics expertise, we are building a robust ophthalmology biosimilar portfolio that addresses critical retinal conditions impacting vision and quality of life. Our biosimilar empowers clinicians with reliable, evidence-based therapeutic options while reducing treatment burden and cost barriers for patients. Through innovation, scientific rigor, and access-driven partnerships, Biocon Biologics is reshaping retinal care and enabling better visual outcomes for patients worldwide.